Evaluation of the effect of zinc sulfate in improving the symptoms of schizophrenia patients

Evaluating the efficacy of zinc sulfat in improving schizophrenic symptoms patients treated with atypic antipsychoties in ahvaz Golestan hospital in the year 1399

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200815048417N1

Enrollment

Registered

2020-10-19

Start date

2020-09-05

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: Intervention group: Patients with schizophrenia treated with atypical antipsychotics? to these patients , Zinc sulfate capsules, 220 mg dose , three times a day for 6 weeks, it is giv

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with schizophrenia treated with atypical antipsychotic drugs Written consent to study The patient is able to take medicine

Exclusion criteria

Exclusion criteria: Organic disease Existance of other disorders such as mental retardation or cognitive problems Need to receive electric shock Allergy to zinc sulfate Pregnant patients Dependance and substance use

Design outcomes

Primary

Measure	Time frame
The effect of Zinc sulfate on the symptoms of Schizophrenia according to the PANSS ( positive and negative and psychopathology symptoms ) questionnaire. Timepoint: At the beginning of the study ( before the intervention ), the second week , the fourth week and the sixth week after starting Zinc sulfate consumption. Method of measurement: Positive and negative and psychopathology symptoms questionnaire.	—

Measure

Time frame

The effect of Zinc sulfate on the symptoms of Schizophrenia according to the PANSS ( positive and negative and psychopathology symptoms ) questionnaire. Timepoint: At the beginning of the study ( before the intervention ), the second week , the fourth week and the sixth week after starting Zinc sulfate consumption. Method of measurement: Positive and negative and psychopathology symptoms questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForouzan Behrouzian

Ahvaz University of Medical Sciences

Fbehrouzian@ gmail.com0098 61 3332368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026